Eargo

Eargo is a California-based medical device company that manufactures and distributes in-ear hearing devices and wireless audio products for the healthcare market.

Business Model:

Revenue: $34.4M

Employees: 201-500

Detailed Eargo Information

Geographic Data

Eargo headquarters map

Address: 2665 North First Street

City: San Jose

State: CA

Zip: 95134

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$125M

Raised Total:

$342M

Metrics

883,561Website Global Rank

40,594Website Monthly Traffic

Twitter Followers

Description

Eargo is a California-based medical device company that manufactures and distributes in-ear hearing devices and wireless audio products for the healthcare market.

Contact Phone:
+16503517700

Contact Email:

Eargo went public on 10/15/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/15/2020

IPO Valuation:
$654M

Ticker Symbol:
EAR

IPO Price:
$18/share

Amount Raised:
$141M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2014 Series A 1 - Peterson Ventures
Peterson Ventures
6/2015 Series A 9 $13.6M Maveron
Red Sea Ventures
Pierre Lamond
Peterson Ventures
Montage Ventures
Farzad (Zod) Nazem
Dolby Family Ventures
Crosslink Capital
Birchmere Ventures
Maveron
10/2013 Series A 1 - Peterson Ventures
Peterson Ventures
10/2017 Series C 5 $45M Nan Fung Life Sciences
Charles Schwab Corporation
Peterson Ventures
New Enterprise Associates
Maveron
Nan Fung Life Sciences
6/2022 Post-IPO Debt $0 Patient Square Capital
Patient Square Capital
12/2018 Series D $52M New Enterprise Associates
The Charles and Helen Schwab Foundation
Maveron
Future Fund
11/2022 Post-IPO Equity $29.3M
11/2022 Post-IPO Equity $29.3M
10/2020 IPO $141.3M
12/2015 Series B 5 $25M New Enterprise Associates
StartX (Stanford-StartX Fund)
Peterson Ventures
Maveron
Dolby Family Ventures
New Enterprise Associates
7/2020 Series E $0 Charles and Helen Schwab Foundation
Longitude Capital
New Enterprise Associates
Gilde Healthcare
Nan Fung Life Sciences
Gilde Healthcare
Longitude Capital
Charles and Helen Schwab Foundation
Longitude Capital
New Enterprise Associates
Gilde Healthcare
Nan Fung Life Sciences
Gilde Healthcare
Longitude Capital
3/2019 Series D 5 $52M Nan Fung Life Sciences
Future Fund
Schwab Institutional
Maveron
Future Fund
New Enterprise Associates
Nan Fung Life Sciences
Future Fund
Schwab Institutional
Maveron
Future Fund
7/2016 Convertible Note 1 - Peterson Ventures
Peterson Ventures
6/2022 Post-IPO Debt 1 $125M Patient Square Capital.
Patient Square Capital
7/2020 Series E 5 $81.6M Maveron
New Enterprise Associates
Gilde Healthcare
Longitude Capital
the Charles and Helen Schwab Foundation
Nan Fung Life Sciences
Charles and Helen Schwab Foundation
Longitude Capital
New Enterprise Associates
Gilde Healthcare
Nan Fung Life Sciences
Gilde Healthcare
Longitude Capital
7/2016 Convertible Note 1 -
7/2014 Series A 1 -
10/2013 Series A 1 -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research